Similar Stories to Exelixis Drug Fails Pivotal Prostate Cancer Study on Bing News

BING NEWS:
  • ASCO: Data detail Verzenio's flop in prostate cancer as Lilly seeks redemption via radiotherapy
    Eli Lilly has in the past few months unveiled two back-to-back trial flops for Verzenio in prostate cancer. Now, we know exactly how one sputtered. | Eli Lilly recently unveiled two back-to-back trial ...
    05/23/2024 - 10:00 am | View Link
  • Research team identifies a new way to treat prostate cancer
    The American Cancer Society estimates there are nearly 300,000 new cases of prostate cancer every year in the U.S., and approximately one in eight men will be diagnosed with prostate cancer in their ...
    05/22/2024 - 9:45 am | View Link
  • New Prostate Cancer Surgery Imaging Technique Could Reduce Side Effects
    Men having prostate cancer surgery often fear side effects that can result from the procedure. These include urinary leakage and erectile dysfunction caused by harm to nerves when the tumor is removed ...
    05/21/2024 - 5:00 pm | View Link
  • A new way to treat prostate cancer
    On the hunt for a better way to shrink prostate tumors.
    05/21/2024 - 1:00 pm | View Link
  • The Targeted Pulse: Agents Targeting Challenges in Brain Cancer, Nivolumab/Ipilimumab Fails in NSCLC, and More
    Experts explore challenges in brain tumor management, and nivolumab/ipilimumab fails to improve PFS in NSCLC. We also cover access to 177Lutetium-PSMA-617, developments in mRNA cancer vaccine WGc-043, ...
    05/20/2024 - 2:58 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News